Paola de Andrade Mello

Author

Harvard University ORCID

Also Known As

Mello, Paola de Andrade, P. de Andrade Mello, Paola De Andrade Mello, Paola de Andrade Mello

Publications

991

Citations

H-Index

Concepts

All Affiliations

Harvard University Beth Israel Deaconess Medical Center Universidade Federal do Rio Grande do Sul Universidade Federal do Rio de Janeiro University of Illinois Chicago

About

Paola de Andrade Mello is an author at Harvard University specializing in medicine, cell death, and sepsis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	295
2	Engineering	1	1	41
3	Biomedical Engineering	1	1	41
4	Cell Biology	1	1	57
5	Cellular Physiology	1	1	57

Paola de Andrade Mello

Publications

459

Citations

H-Index

Page 1

	Year	Citations
CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury Luiz Eduardo Baggio Savio, Paola de Andrade Mello, Vanessa Ribeiro Figliuolo, Journal of Hepatology InflammationCytokineHepatologySepsis-induced Liver InjuryLiver Physiology	2017	175
P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction Luiz Eduardo Baggio Savio, Mariana G. Juste Andrade, Paola de Andrade Mello, Molecular Neurobiology InflammationMolecular PhysiologyImmunologyP2x7 ReceptorCell Death	2016	63
Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells Paola de Andrade Mello, Eduardo Cremonese Filippi‐Chiela, Jéssica Nascimento, Molecular Biology of the Cell ApoptosisCell DeathPathologyCell Death MechanismsCellular Physiology	2014	57
Hyperthermia and associated changes in membrane fluidity potentiate P2X7 activation to promote tumor cell death Paola de Andrade Mello, Bian Shu, Luiz Eduardo Baggio Savio, Oncotarget	2017	51
Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line Luíza Abrahão Frank, Rafaela P. Gazzi, Paola de Andrade Mello, European Journal of Pharmaceutics and Biopharmaceutics NanomedicineEngineeringCervical CancerPolymer-drug ConjugateNano-drug Delivery	2019	41
P2X7 receptor activation increases expression of caveolin-1 and formation of macrophage lipid rafts, thereby boosting CD39 activity Luiz Eduardo Baggio Savio, Paola de Andrade Mello, Stephanie Alexia Cristina Silva Santos, Journal of Cell Science	2020	30
Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models Haohai Zhang, Lili Feng, Paola de Andrade Mello, Journal of Clinical Investigation	2022	26
Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases Elizabeth H. Zhong, Carola Ledderose, Paola de Andrade Mello, American Journal of Physiology-Cell Physiology	2020	16

Page 1